Dr. Javaid I. Sheikh is an internationally renowned medical executive and creative thought leader in global academic medicine. Since beginning his tenure as Dean of Weill Cornell Medicine-Qatar (WCM-Q) in 2010, Dr. Sheikh has pioneered and implemented innovative biomedical educational and research programs enabling WCM-Q to become widely acknowledged as a leading institution preparing “Global Physicians” for the 21st century. Further, the establishment of a comprehensive research infrastructure with core laboratories (e.g., genomics, proteomics, transcriptomics, metabolomics) as national resource that allows WCM-Q to perform and apply deep molecular phenotyping of the population in Qatar, as well as the application of personalized medicine approaches to complex diseases such as diabetes.

Most recently, Dr. Sheikh has launched an Artificial Intelligence (AI) Center for Precision Health. The Center will leverage novel AI tools, such as refined data analytics and algorithms, from large volumes of data using mobile apps, wearable sensors, and electronic health records (EHR) to promote optimal health and wellness. Such approaches, combined with Population Health science orientation, should lead to enhanced healthy lifespan for the populace.

Dr. Sheikh co-founded Innovations in Global Health Professions Education (https://www.innohealthed.com/), a globally interconnected forum providing an international platform for profiling conceptual and technological innovations in health professions education. He also serves on the Artificial Intelligence in Health Professions Education forum of the National Academy of Medicine in the US.

Prior to joining WCM-Q, Dr. Sheikh built a distinguished career as a Professor of Psychiatry and Behavioral Sciences, Associate Dean, and Chairman of the Board at the Palo Alto Institute for Research and Education at Stanford University School of Medicine and affiliated hospitals in California.

Hajar A. Albinali, MD, FACC, FESC, FGHA, Senior Cardiology Consultant, Director of Medical Education in Heart Hospital. He was a former Managing Director of HMC, Chairman of Cardiology & Cardiac Surgery, Undersecretary of Health and Minister of Health and past President of GHA.

Dr. Nidal Asaad, MBBS, FRCPC – Senior Cardiology Consultant, CEO, Medical Director and Head of Cardiac Electrophysiology at Heart Hospital in Qatar and an Associate Professor at Weill Cornell Medical College. Dr. Asaad is actively involved in cardiovascular research and Gulf region registries with more than 100 publications in peer review journals. He is certified in internal medical cardiology and cardiac electrophysiology from University of Toronto and University of Ottawa Heart Institute. He is a member of the steering committee for the Gulf Heart Rhythm Society and has been a member of the Arab Board of Examiners in Cardiology for over 10 years.

Doctor Uwe Zeymer is interventional Cardiologist at the University Heart Center Freiburg, Department of Cardiology, Germany. He is Vice-Director of the Institut für Herzinfarktforschung Ludwigshafen. He has been board certified in internal medicine, cardiology, interventional cardiology and intensive care medicine.

After his graduation from Medical School at the Universities of Munich and Marburg in 1985, Dr Zeymer gained experience as a resident, fellow and attendee in the Department of Cardiology, Municipal Hospital, Kassel, and as a clinical research fellow in the Department of Cardiology, Cedars-Sinai Medical Center, Los Angeles, USA. He is full Professor of Medicine at the University of Göttingen.

Dr. Zeymer is or has chaired or been a member of the Steering Committee numerous trials in patients with acute coronary syndromes, antithrombotic therapies and anticoagulants. In addition, he has been chair or member of the Steering committee of several international registries in interventional cardiology, treatment of hypertension, anticoagulation for atrial fibrillation and acute coronary syndromes. He has been co-chairman of the largest randomized clinical studies in patients with infarct-related cardiogenic shock, such as the IABP-SHOCK 2 trial, the CULPRIT-Shock trial and the ECLS-Shock trial.

Dr. Zeymer has authored and co-authored over 600 scientific papers on cardiovascular disease in journals such as the New England Journal of Medicine, Lancet, JAMA, European Heart Journal, Circulation and Journal of the American College of Cardiology.

Dr. Zeymer is member of the editorial board of Clinical Research in Cardiology, European Heart Journal Acute Cardiovascular Care and is European Editor for Cardiology and Therapy

Dr. Zeymer has been the Board member Chair of the Scientific Committee of the Association for Acute Cardiovascular Care (ACVC) of the ESC, the Chair of the Working Group of Thrombosis of the German Cardiac Society and the Chair of the Working for Quality Insurance and Registries of the German Cardiac Society. He is the past and current chair of the STEMI Registry of the European Society of Cardiology.

Prof. Carlo Di Mario is Professor of Cardiology at the University of Florence and Director of the Structural 
Interventional Cardiology Division of the University Hospital Careggi, Florence, Italy. He is still clinically active in London where he holds GMC registration and offers consultations in the Royal Brompton Hospital and PCI/TAVI in the Harley Street Clinic. Previous posts included 15 years as 
Professor of Clinical Cardiology at Imperial College of Sciences, Medicine & Technology, London and Consultant Cardiologist at 
the Royal Brompton Hospital. He also practiced at the San 
Raffaele University Hospital, Milan, Italy. He trained in Cardiology at the University of Padova, Italy, but he soon moved for interventional training at the Thoraxcentre of Rotterdam, the Netherlands, where he also completed a PhD in Intracoronary Ultrasound Imaging and Doppler.

Chief, Sydell and Arnold Miller Family Heart, Vascular & Thoracic Institute Delos M. Cosgrove, MD, Chair for Heart Disease Research Professor of Surgery, Thoracic & Cardiovascular Surgery Cleveland Clinic

With more than 700 peer-reviewed articles published, multiple patents, and 19 inventions, Dr. Svensson was named one of the most influential researchers of the past decade. Dr. Svensson helped establish HVTI-sponsored continuing medical education at Cleveland Clinic. His research focuses on aortic valve surgery, surgery for thoracic aortic aneurysms, minimally invasive valve surgery, and percutaneous valve treatment, but also reported the first replacement of the entire aorta from the aortic valve to the aortic bifurcation in one operation. Through research and clinical practice, Dr. Svensson has contributed to advances in protecting the brain, spinal cord, and kidneys during major cardiac and aortic surgery, and has been instrumental in developing minimally invasive keyhole surgical techniques (J-incision).

Maan Fares, MD, is Chair of Global Patient Services at Cleveland Clinic, an $8 billion health system with locations in Ohio, Florida, Nevada, Canada, Abu Dhabi, and London. He has held the position from 2021, having served as Vice Chairman since 2015.

Dr. Fares is a board-certified, clinical cardiologist who has served at Cleveland Clinic from 2013 in the Robert and Suzanne Tomsich Department of Cardiovascular Medicine in the Sydell and Arnold Miller Family Heart, Vascular & Thoracic Institute at Cleveland Clinic. From 2022, he is also an Associate Professor of Medicine in the Cleveland Clinic Lerner College of Medicine, Case Western Reserve University.

Dr. Fares earned his medical degree from the University of Damascus, School of Medicine, Syria. He completed a residency at Cleveland Clinic, Cleveland, Ohio, and a fellowship in cardiovascular medicine at New England Medical Center, Boston, Massachusetts. Dr. Fares spent time on staff at the Massachusetts General Hospital, Boston, as a clinical associate in echocardiography while on the medical staff of Melrose Wakefield Hospital, Melrose, Massachusetts.

Prior to his appointment to the Cleveland Clinic medical staff in 2013, Dr. Fares was a member of the Ohio Permanent Medical Group/Kaiser Permanente medical staff and Chief of Cardiology. Additional positions he held with Kaiser include Associate Medical Director for Medical Specialties and member of the Board of Directors.

Peter Clemmensen graduated as MD at the University of Copenhagen, currently Professor of Cardiology at the Department of Cardiology, University Heart and Vascular Center, Hamburg-Eppendorf, Previous President the Acute Cardiovascular Care Association, Past President of the Danish Heart Foundation. Professor Clemmensen has published more than 400 scientific papers (N Engl J Med, Lancet, Circulation, Eur Heart J, J Am Coll Cardiol, Am Heart J, Am J Cardiol, Heart) and authored chapters in international textbooks. H-Index 66. Research interests include reperfusion therapies and organisation in patients with STEMI, antithrombotic therapy and electrocardiology. Professor Clemmensen mentored 14 completed dissertations. Participated in many clinical trials and registries ranging from investigator to Steering Committee functions: FRISC II; DANAMI1-3; PLATO; EUROMAX; TRILOGY; MULTIPRAC; CULPRIT SHOCK; ECLS SHOCK. He has served on several national and international end-points committees and DSMB´s as well as working groups including the Joint ESC/ACC/AHA/WHO Committee for redefinition of myocardial infarction 2000, and its 2004-2012 GLOBAL MI Task Force.

Dr. Maryam is a Consultant Cardiologist with over a decade of experience at King Fahad Specialist Hospital in Dammam, the only tertiary and quaternary cancer center in the Eastern Province of Saudi Arabia under the Ministry of Health. With specialized interests in heart failure and cardio-oncology, Dr. Maryam has been instrumental in establishing dedicated cardio-oncology services aimed at supporting cancer patients through their treatment journeys while minimizing the risk of cardiotoxicities. In addition to clinical practice, Dr. Maryam serves as the Group Vice President of Quality and Performance at the Eastern Health Cluster, where he is committed to delivering world-class, person-centered, and value-based healthcare across the region. His work aligns with the pursuit of the quadruple aim: improving health outcomes, enhancing patient experience, increasing value, and fostering joy in the workplace.
She completed his undergraduate and postgraduate fellowship training through the Royal College of Surgeons in Ireland and Beaumont Hospital in Dublin. He is also a Fellow of the Royal College of Physicians and Surgeons in Glasgow and holds an MSc in Healthcare Administration from RCSI-Bahrain, among other certifications. An active contributor to academic research, Dr. Maryam has played a key role in authoring the national heart failure guidelines in Saudi Arabia over the past seven years.

Dr Wael Abdulrahman Almahmeed is a Consultant Cardiologist at the Heart and Vascular Institute in Cleveland Clinic Abu Dhabi. He is also a Clinical Professor at the Khalifa University and has an Adjunct Staff position at Cleveland Clinic, Ohio.

Dr Almahmeed completed his undergraduate medical training at the medical school in the University of Southampton, England. He continued his post graduate studies in Internal Medicine and Cardiology at the University of British Columbia, Vancouver, Canada. This was followed by a fellowship in Echocardiography at the same institution.

He received his Fellowship of the Royal College of Physicians and Surgeons of Canada in Internal Medicine in 1994 and in Cardiology in 1995. Subsequently he became a Fellow of the American College of Chest Physicians (1996), Fellow of the American College of Physicians (1998), Fellow of the American College of Cardiology (1998) and Fellow of the European Society of Cardiology in 2004.

He is a foundation member of the Gulf Heart Association and the Emirates Cardiac Society. Under his leadership in the Emirates Cardiac Society, the Society won the bid to host the World Congress of Cardiology in Dubai in 2012, the World Tobacco or Health Congress in Abu Dhabi in 2015, the Asia Pacific Congress of Cardiology in Abu Dhabi in 2015 and World Congress of Pediatric Cardiology in 2016. He also established an annual meeting for the Emirates Cardiac Society in UAE. In 2000, he initiated World Heart Day in the UAE. Today it is celebrated by many institutions across the country.

Dr Almahmeed's research interests include Coronary Artery Disease prevention in the developing countries, Hypertension, Dyslipidemia, and Registries on Acute Coronary Syndromes, Heart Failure and Atrial Fibrillation. He was the national coordinator for the Inter-Heart Study. He is on the steering committee of the Gulf Race, Gulf Coast, Gulf Care and Gulf Safe Registries. He has over 350 publications to his credit, and is currently the national coordinator for a number of Multi-Center Trials including Elixa, Examine and Garfield Trials.

Professor Jordi Bañeras, MD, PhD, MSc, M.Ed, is a cardiologist specializing in cardiovascular critical care at Vall d’Hebron University Hospital in Barcelona. He holds multiple advanced degrees in medicine, research, and medical education, and earned his PhD in Medicine Cum Laude from the Autonomous University of Barcelona. He serves as Associate Professor of Medicine at the University of Barcelona and CTO Professor of Cardiology.
Prof. Bañeras is a leader in medical simulation and education, coordinating the Vall Hebron Advanced Simulation Center and co-creating SIMOONS, an award-winning virtual simulation platform. He has published over 50 peer-reviewed articles and actively contributes to international conferences, research, and peer review.
He currently chairs the Education section of the ESC’s Acute Cardiovascular Care (ACVC) and sits on the ESC Education Committee. His work extends internationally, including collaborations with the AHA, ACC, and observerships in the U.S. He is also involved in public health initiatives, especially around CPR training and air pollution awareness.

Dr. Mehra is the William Harvey Distinguished Chair in Advanced Cardiovascular Medicine, a Professor of Medicine at Harvard Medical School and Executive Director of the Center for Advanced Heart Disease at Brigham and women’s Hospital and Harvard Medical School in Boston, Massachusetts. He also served as founding Medical Director of the Heart and Vascular Center (2013-2019) at the Brigham and was Editor-in-Chief, The Journal of Heart and Lung Transplantation, which rose to #1 ranked journal in its field under his leadership (2010-2020). Dr. Mehra is the only individual to have been appointed as President (2008) of the International Society of Heart and Lung Transplantation (ISHLT) and President of the Heart Failure Society of America (HFSA), the two premier societies in the field of advanced heart disease. He has authored over 500 scholarly papers with a specific focus on Advanced Heart Failure and among some highlights, discovered the obesity paradox in heart failure, described the natural history of cardiac allograft vasculopathy after transplantation, established the pivotal international guidelines for selection and care of transplant patients, defined the role of new immunosuppression to improve transplant outcomes and helped introduce genomic based biomarkers for evaluating cardiac allograft rejection. In recent years his research focus shifted to evaluation of novel left ventricular assist devices (“artificial heart pumps”) engineered to reduce the burden of adverse effects and allow use in broader populations of patients. This work published in the New England Journal of Medicine has resulted in the introduction of novel therapy for advanced heart failure patients and its practice changing implications have been seen around the world in advanced heart failure. Dr. Mehra has a certificate in Executive leadership from the Harvard Business School and completed a Master of Science in Health Economics and Management at the London School of Economics in 2018, a degree earned through his designation as a “Braunwald Scholar”.

10% discount applies to both Economy and Business Class for the following countries.

Please note that this offer will not be included with ongoing promotions.

United Arab Emirates (AE)
Austria (AT)
Azerbaijan (AZ)
Bosnia Herzegovina (BA)
Belgium (BE)
Bulgaria (BG)
Bahrain (BH)
Brazil (BR)
Canada (CA)
Switzerland (CH)
Cyprus (CY)
Czech Republic (CZ)
Denmark (DK)
Algeria (DZ)
Spain (ES)
France (FR)
United Kingdom (GB)
Georgia (GE)
Greece (GR)
Croatia (HR)
Hungary (HU)
Ireland (IE)
Iraq (IQ)
Iran (IR)
Italy (IT)
Jordan (JO)
Kuwait (KW)
Kazakhstan (KZ)
Lebanon (LB)
Netherlands (NL)
Norway (NO)
Oman (OM)
Poland (PL)
Portugal (PT)
Romania (RO)
Serbia (RS)
Russian Federation (RU)
Saudi Arabia (SA)
Sweden (SE)
Turkey (TR)
United States of America (US)
Uzbekistan (UZ)